Trial Information

Summary: ACOSOG Z4032: A Randomzied Phase III Study of Sublobar Resection Versus Sublobar Resection Plus Brachytherapy in High-Risk Patients with Non-Small Cell Lung Cancer (NSCLC), 3cm or Smaller

You have been asked to participate in this research study because you have Stage I non-small cell lung cancer (NSCLC) or a spot on your lung that your doctor feels is suspicious for NSCLC.  Stage I NSCLC means that your cancer is in the early stages, smaller or equal to 3 centimeters (about 1/10^th of an inch) in size with no evidence of spread to lymph nodes or other organs. You also have weakened cardiopulmonary reserve. Your doctor is recommending an operation to remove this cancer. The purpose of this study is to compare the results of sublobar resection (removal of a small portion of a lung) with sublobar resection plus brachytherapy (local radiation therapy) to see which of these two treatments is better. Another purpose is to determine the quality of life for patients receiving the treatments given on this study.  Your treatment on this study and active follow up is expected to last 36 months (about 3 years) after your operation.  Your doctor or an authorized researcher will continue to contact you by telephone or by mail at least once a year for 2 more years.

Patient Inclusion/Exclusion Criteria:

- See http://clinicaltrials.coh.org for additional information.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 2, 2008 at 2:50:55 PM